InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Emergent BioSolutions Inc.

EBS Clue Score47
United States Fiscal year ends December CIK 0001367644 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Donald W DeGolyer
7 Oct 2026
Director
Sold on a plan
17,800
$7.09
$126.20K
Paul Anthony Williams
1 Oct 2026
SVP, Products Business
Sold on a plan
3,000
$6.53
$19.59K
Paul Anthony Williams
1 Jul 2026
SVP, Products Business
Sold on a plan
3,000
$8.40
$25.20K
Kathryn C Zoon
1 May 2026
Director
Sold on a plan
1,057
$8.97
$9.48K
Kathryn C Zoon
1 May 2026
Director
Sold on a plan
16,145
$8.36
$134.97K
Donald W DeGolyer
1 May 2026
Director
Sold on a plan
954
$8.96
$8.55K
Donald W DeGolyer
1 May 2026
Director
Sold on a plan
14,527
$8.36
$121.45K
Sujata Tyagi Dayal
1 May 2026
Director
Sold on a plan
980
$8.94
$8.76K
Sujata Tyagi Dayal
1 May 2026
Director
Sold on a plan
12,781
$8.36
$106.85K
Keith Katkin
30 Apr 2026
Director
Sold on a plan
15,481
$8.28
$128.18K
Paul Anthony Williams
1 Apr 2026
SVP, Products Business
Sold on a plan
4,000
$8.44
$33.76K
Ronald Richard
5 Dec 2025
Director
Sold after exercise
14,884
$11.90
$177.09K
Ronald Richard
5 Dec 2025
Director
Sold after exercise
7,100
$12.11
$85.99K
Donald W DeGolyer
10 Nov 2025
Director
Sell
17,801
$10.54
$187.62K
Sujata Tyagi Dayal
7 Nov 2025
Director
Sell
8,552
$10.00
$85.52K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 2
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,343,897
History held since 21 Nov 2006